The Journal of Controlled Release is a bimonthly peer-reviewed medical journal and the official journal of the Controlled Release Society. The journal contains papers detailing research involving the controlled release and delivery of drugs and other biologically active agents. Announcements and reports of future meetings pertaining to the activities of the Controlled Release Society are also included. The journal is abstracted and indexed in BIOSIS Previews, CAB Abstracts, Chemical Abstracts, Current Contents/Life Sciences, EMBASE, MEDLINE, Science Citation Index, and Scopus.
Antibiotic resistant bacteria are a threat to human lives, and yet the development of new drugs to treat bacterial infections is slow. A group of proven drugs used in cancer treatment for decades could possibly be the solution. ...
Bio & Medicine
Sep 25, 2023
0
38
A special type of starch could soon be used as an excipient in medicine to improve the treatment of patients. A research team from Martin Luther University Halle-Wittenberg (MLU) has discovered that it makes a suitable drug ...
Biochemistry
Aug 22, 2023
0
3
Chemotherapy is a mainstay of cancer treatment. While effective, this therapy indiscriminately kills rapidly dividing cells—cancerous or otherwise—so patients frequently experience severe side effects, ultimately limiting ...
Bio & Medicine
Aug 9, 2023
0
18
University of Queensland researchers have developed a nanoparticle to take a chemotherapy drug into fast growing, aggressive brain tumors.
Bio & Medicine
May 31, 2023
0
39
Gene therapy is a potential mode of treatment for a wide variety of diseases caused by genetic mutations. While it has been an area of diverse and intense research, historically, only a very few patients have been treated ...
Bio & Medicine
Mar 2, 2023
0
3
It's "lights out" for antibiotic-resistant superbugs as next-generation light-activated nanotech proves it can eradicate some of the most notorious and potentially deadly bacteria in the world.
Bio & Medicine
Jan 16, 2023
0
307
How can a drug be delivered exactly where it is needed, while limiting the risk of side effects? The use of nanoparticles to encapsulate a drug to protect it and the body until it reaches its point of action is being increasingly ...
Bio & Medicine
Nov 9, 2022
0
36
Cancer immunotherapies, such as immune checkpoint inhibition therapy, have been attracting attention in recent years as new methods for treating cancer. However, immune checkpoint inhibition therapy is only effective in 20%–30% ...
Bio & Medicine
Oct 31, 2022
0
5
A research team, affiliated with UNIST has unveiled a new substance that inhibits cancer growth by inducing apoptosis in cancer cells.
Bio & Medicine
Oct 20, 2022
0
18
Viruses attack the body by sending their genetic code—DNA and RNA—into cells and multiplying. A promising class of therapeutics that uses synthetic nucleic acids to target and shut down specific, harmful genes and prevent ...
Molecular & Computational biology
May 17, 2021
0
8
